fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
Published 6 years ago • 163 plays • Length 11:32
Download video MP4
Download video MP3
Similar videos
-
8:12
fda approvals in hcc, sclc, and nsclc, priority review in rare blood cancer, and more
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
7:57
fda approvals in breast cancer and melanoma, disappointing results in hnscc, and more
-
9:07
fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
10:41
fda approvals in ovarian cancer and for mec chemo, promising data in lung cancer, and more
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
8:07
fda approval in lung cancer, priority reviews in hcc and nhl, and an odac recommendation
-
6:09
fda approvals in breast cancer and hodgkin lymphoma, 2017 sgo highlights, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
7:23
fda approval in nsclc, priority review in sclc, 2018 sabcs highlights, and more
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
9:08
fda approvals in cervical cancer, ovarian cancer, and cll, and more
Clip.africa.com - Privacy-policy